01:12:36 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Ndatalyze Corp
Symbol NDAT
Shares Issued 26,121,425
Close 2022-09-15 C$ 0.21
Market Cap C$ 5,485,499
Recent Sedar Documents

Ndatalyze hopes to receive initial revenue by year-end

2022-09-15 16:50 ET - News Release

Mr. James Durward reports

YMI MARKETING CAMPAIGN BEGINS

Ndatalyze Corp.'s initial marketing campaign for its advanced YMI mental health platform has progressed to the implementation stage. The campaign is focused on the Canada-wide market and expected to run over the next few months. The campaign was designed to test the effectiveness of a variety of marketing channels such as social media, search, display, video and native ads. Coincident with the campaign, the corporation will refine its referral programs involving both the consumer mHealth market and the business-to-business psychotherapist market. It is expected that initial revenues will be achieved before the end of the year in advance of the refined release of YMI into the U.S. market. The campaign is fully financed by the corporation's existing cash balance.

Ndatalyze's president, Jim Durward, stated: "With the YMI platform being fully functional, the marketing strategy set and mental health remaining a top concern of the general public, we believe this is a right place at the right time scenario. Now is the time to execute."

About Ndatalyze Corp.

Ndatalyze generates technology-based, health-related solutions. The YMI division is developing a machine-learning-based, on-line consumer mental health application with its database licensing division focusing on providing a specialized health-related reference database to application developers and researchers. YMI is based on the corporation's proprietary reference database consisting of greater than 1,200 biometric records complete with associated electroencephalogram (EEG) data. With installations worldwide, its Medxtractor division manufactures small-scale bioextractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, YMI is in development, and accordingly, the corporation cannot accurately predict if or when this application will become a cash flow generator.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.